UNSPSC 85681504: Revision of autologous tissue substitute in facial bone, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in facial bone, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0NWW37Z

UNSPSC 85681504 Revision of autologous tissue substitute in facial bone, percutaneous approach is a Commodity code that shows no meaningful alignment between its nominal scope and recent state and local procurement activity tagged under it. The recent opportunities on record—independent medical evaluations for pension disability determinations, surgical procedure carve-out benefit programs, occupational medical surveillance, detention-facility emergency and specialty care, pharmacy benefit management, and temporary health professional staffing—are generalist healthcare administration and staffing services unrelated to orthopedic facial bone revision procedures. State and local procurement offices appear to be using this code as a catch-all or administrative classifier rather than as a taxonomy match to the underlying work being solicited.

The issuing bodies include city retirement offices (Phoenix), municipalities (Long Beach), state transportation departments (Washington State Department of Transportation), counties (Harris, Collier, Santa Clara), and regional health systems. Geographic spread covers Arizona, California, Washington, Florida, and Texas across the recent six opportunities posted between mid-July and mid-September 2026. The code currently does not support a pursuit decision—the nominal commodity scope (orthopedic revision procedures) bears no relationship to the actual goods or services state and local governments are buying under this classification, making it unsuitable as a market intelligence or targeting tool for any vendor focused on facial bone reconstruction or autologous tissue work.